Xspray Pharma

Share Issue/Capital Change • May 31, 2024

New number of shares and votes in Xspray Pharma after TO6

Xspray Pharma AB (Nasdaq Stockholm: XSPRAY) today announces that the number of shares and votes in Xspray Pharma AB has changed. New shares have been issued and registered through the subscription of warrants series TO6 2023, which ended on May 2, 2024. In total, the number of outstanding shares and votes has increased by 2,508,723.

The number of shares has increased by 2,508,723 from 31,253,542 to 33,762,265. The share capital has increased by SEK 2,508,723, from SEK 31,253,542 to SEK 33,762,265.

For further information, please contact:

Kerstin Hasselgren Senior Advisor & Investor Relations Xspray Pharma AB Mob: +46 (0) 70 311 16 83 E-mail: kerstin.hasselgren@xspray.com

About Xspray Pharma

About Xspray Pharma AB

Xspray Pharma AB (publ) is a pharmaceutical company focused on the development of improved PKIs for cancer treatment, leveraging its proprietary HyNap™ technology platform. The company aims to enhance clinical outcomes for cancer patients by improving the efficacy, safety, and patient experience of existing cancer therapies. Xspray Pharma's shares are traded at Nasdaq Stockholm (Nasdaq Stockholm: XSPRAY). For more information about Xspray Pharma AB and its innovative approach to cancer treatment, please visit www.xspraypharma. com.

This information is information that Xspray Pharma AB is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 2024- 05-31 17:30 CEST.

Attachments

New number of shares and votes in Xspray Pharma after TO6